Skip to main content
. 2022 Oct 21;29(10):7964–7978. doi: 10.3390/curroncol29100630
AS Active surveillance
PCa Prostate cancer
GSU Gleason score upgrade
LR Low-risk
FIR Favorable intermediate-risk
UIR Unfavorable intermediate-risk
NCCN National Comprehensive Cancer Network
CSM Cancer-specific mortality
SEER Surveillance, Epidemiology, and End Results Program
ISUP International Society of Urological Pathology
AUA American Urological Association
CSS Cancer-specific survival
OS Overall survival
PSA Prostate-specific antigen